MEDASCA

Initiative at a glance

MEDASCA team is committed to a rigorous scientific approach based on published research in the field of aging biology. Recent studies have shown that there are specific types of cells, for instance, cytokines, senescent cells etc., that are involved and could even be the key players in the aging process. These cells accumulate in tissues over time and contribute to age-related degeneration and dysfunction within the body.

It is believed that senescent cells are essentially "zombie" cells that have ceased to divide but remain metabolically active, secreting harmful substances that can cause inflammation and damage to surrounding tissues. Research has demonstrated that clearance of senescent cells in animal models leads to improvements in various age-related conditions, indicating their pivotal role in the aging process. However the reason for these cells to appear is not yet conclusive.

Through our research efforts, we seek to discover the mechanism that triggers the aging processes in a human body and to develop novel therapies that specifically target and eliminate these triggers. By reducing the concentration of these detrimental cells, we anticipate a deceleration in the aging process and potentially, the reversal of certain age-related changes.

The implications of our research could revolutionize the way we perceive aging and pave the way for groundbreaking anti-aging treatments. By pinpointing the cellular mechanisms underlying aging and devising strategies to manipulate them, we are hopeful of extending human health span and enhancing quality of life.

In conducting our research, the team upholds the highest ethical standards, prioritizing the safety and well-being of individuals. We acknowledge the complexities and potential risks associated with genetic interventions and are therefore focused on alternative approaches that involve precise targeting of specific cell populations.